Clinical Trial Update: IMI PROTECT(WP2): Antidepressants & Fractures

View source ↗

Summary

A completed IMI PROTECT WP2 trial sponsored by GlaxoSmithKline examining fracture risk associated with antidepressants in patients with depression and postpartu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Major Depressive Disorder
• Postpartum Depression

Snippet

Sponsor: GlaxoSmithKline | Conditions: Depression, Postpartum | Status: COMPLETED